EGFR and neoplasm: Epidermal growth factor receptor mutations were, however, more frequently observed in tumours with BAC component than those without BAC component (78.9 vs 42.9%, P<0.001, odds ratio: 5.0, 95% confidence intervals: 2.0–12.6).